A carregar...

Mutations in PIK3CA sensitize breast cancer cells to physiologic levels of aspirin

A review of the literature finds that women diagnosed with breast cancer, who were on an aspirin regimen, experienced a decreased risk of distant metastases and death. Several recent studies have reported an improvement in overall survival in colorectal cancer patients who harbored mutations in the...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Breast Cancer Res Treat
Main Authors: Turturro, Sanja B., Najor, Matthew S., Ruby, Carl E., Cobleigh, Melody A., Abukhdeir, Abde M.
Formato: Artigo
Idioma:Inglês
Publicado em: Springer US 2016
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4788696/
https://ncbi.nlm.nih.gov/pubmed/26915040
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10549-016-3729-8
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!